NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/19/2025
Back to search
Official data from USPTO
LIVITECH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079332314Class
1, 5, 9, 10, 42, 44
Filing
79332314
Registration
7117212
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
06/20/2025
Trademark type
Combined
Nice classes
1, 5, 9, 10, 42, 44
Filing date
12/02/2021
Registration date
07/25/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/25/2023
Last transaction
06/20/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
33
Owner location
FR
Examiner
MCGILL, CIERRA
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "LIVITECH" with the letters "LIVI" in dark blue and the word "TECH" in light blue, all to the right of a design of twelve tilted squares with six tilted squares in light blue and six tilted squares in dark blue with the four largest tilted squares in the center connected by straight lines to a smaller tilted square each, with two of the lines in dark blue and two of the lines in light blue. The gray background behind the tilted square design represents shading and/or transparent and is not a feature of the mark.
Holders and representatives
Holders
GENFIT
Representatives
Ronald M. Kachmarik Cooper Legal Group, LLC
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Reagents for chemical analyses for scientific use; reagents for scientific use; reagents for scientific or medical research use; diagnostic reagents for scientific use; reagents for immunoserology and molecular diagnosis for research use; chemical reagents for genetic research; in-vivo diagnostic reagents for scientific use; diagnostic reagents for scientific use or for research use; diagnostic reagents for in-vitro use in biochemistrymolecular biologyclinical chemistry and microbiology for research use; all these goods exclusively in the field of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases; and none of them related to telemedicines servicesonline medical consultation and online medical assistance provided to the public
Class 5
Pharmaceuticals for use in human or veterinary medicinefor scientific use for the treatment of inflammatory diseases and liver diseases; chemical preparations for use in human or veterinary medicinefor pharmaceutical usefor the treatment of inflammatory diseases and liver diseases; biological preparations for use in human or veterinary medicinefor pharmaceutical usefor the treatment of inflammatory diseases and liver diseases; preparations for use in human or veterinary medicinefor pharmaceutical usefor the treatment of inflammatory diseases and liver diseases; microorganism cultures for use in human or veterinary medicinefor pharmaceutical use; cell preparations for use in human or veterinary medicinefor pharmaceutical usein particular for gene therapy and cell therapycell growth media; blood and blood derived samplesnamely plasmaserumplatelet free samples for medical use; diagnostic biomarker reagent products for use in human or veterinary medicine; diagnostic reagents for use in human or veterinary medicine; all these goods exclusively in the field of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases; and none of them related to telemedicines servicesonline medical consultation and online medical assistance provided to the public
Class 9
Downloadable software for use in diagnosis of inflammatory diseases and liver diseases; downloadable software applications for use in diagnosing medical conditions; scientific apparatus and instruments especially for recordingprocessingreproducingtransmitting dataelectronic data loggers and recorders; data processing equipment; all these goods exclusively in the field of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases; and none of them related to telemedicines servicesonline medical consultation and online medical assistance provided to the public
Class 10
Medical apparatusinstruments and equipmentDNARNA and protein analysis apparatusDNARNA and protein quantifiersmedical devices for measuring DNARNAbiochemical and physical parametersnamely concentration of biomarkers relating to the evaluation of inflammatory and liver diseases and blood analyzers for evaluation of inflammatory and liver diseases; instruments and tools for medical diagnosiscomputer displays and computer monitors and controllers therefor used in direct association with medical diagnosis apparatus during the process of diagnosis of a condition in an individual; diagnostic apparatus for medical usemedical diagnostic apparatus for testing the biomarker levels; all these goods exclusively in the field of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases; and none of them related to telemedicines servicesonline medical consultation and online medical assistance provided to the public
Class 42
Pharmaceutical researchresearch for the discovery of new medicines; scientific researchespecially in the medicalbiomedicalchemicalgeneticpharmaceutical field; basic and applied scientific research; technical scientific research; scientific researchsorting and selection of molecules; scientific research servicesdevelopment and validation of biological testscellular tests and genetic tests; scientific researchfunctional genomics for identifyingcharacterizingvalidating and developing biologically active molecules; analysis of biological substances in biological fluids; computer programming in the field of scientific research and for the pharmaceutical industry; engineering servicessurveying; technical project study being scientific research; professional consultancy unrelated to business dealings in the field of scientific and medical research; research and development of new pharmaceutical products for others; scientific research in the field of pharmacy; all these services exclusively in the field of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases; and none of them related to telemedicines servicesonline medical consultation and online medical assistance provided to the public
Class 44
Medical analysis relating to the diagnosis and treatment of persons and medical diagnosis services in inflammatory diseases and liver diseases; medical analyses of blood samplesbiological preparations and biological fluids relating to the diagnosis and treatment of persons; support services in the field of medicinehealth care and pharmaceutical researchmedical analysis for the diagnosis and treatment of patients; medical information; provision of medical information; all these services exclusively in the field of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases; and none of them related to telemedicines servicesonline medical consultation and online medical assistance provided to the public
Publications
History of USPTO decisions and trademark events.
45 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/21/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/26/2023
FIMP
FINAL DISPOSITION PROCESSED
10/25/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/25/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
07/25/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/25/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
07/25/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/05/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/05/2023
GPNX
NOTIFICATION PROCESSED BY IB
05/10/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/09/2023
PUBO
PUBLISHED FOR OPPOSITION
05/09/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/19/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/19/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/19/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/30/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/29/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/29/2023
RFNT
REFUSAL PROCESSED BY IB
03/29/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/01/2023
GNRT
NON-FINAL ACTION E-MAILED
03/01/2023
CNRT
NON-FINAL ACTION WRITTEN
03/01/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/26/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/25/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/25/2023
DOCK
ASSIGNED TO EXAMINER
01/17/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/02/2023
GNFR
FINAL REFUSAL E-MAILED
01/02/2023
CNFR
FINAL REFUSAL WRITTEN
01/02/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/27/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/27/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/24/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/24/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/24/2022
RFNT
REFUSAL PROCESSED BY IB
05/25/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/29/2022
RFRR
REFUSAL PROCESSED BY MPU
04/29/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/18/2022
CNRT
NON-FINAL ACTION WRITTEN
03/17/2022
DOCK
ASSIGNED TO EXAMINER
03/17/2022
MAFR
APPLICATION FILING RECEIPT MAILED
02/08/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/04/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/03/2022
Continuous trademark protection
Get notified about every new filing that threatens LIVITECH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.